<DOC>
	<DOCNO>NCT02014181</DOCNO>
	<brief_summary>Flaxseed ( FS ) safe well tolerate supplement ability fight inflammation oxidative stress - byproduct daily stress human body face everyday especially chronic disease . Cystic fibrosis ( CF ) genetic disease result mutation sodium chloride transport channel result pancreatic insufficiency , chronic sinusitis chronic lung infection . The investigator hypothesize chronic inflammation oxidative stress part chronic exacerbation part cystic fibrosis . The investigator believe flaxseed anti-inflammatory antioxidative property help dampen stressor CF lung potentially result few exacerbation CF , few antibiotic , few hospitalization , improve well-being .</brief_summary>
	<brief_title>Flaxseed Modulates Inflammation Oxidative Stress CF</brief_title>
	<detailed_description>Ten patient steady-state cystic fibrosis ( CF ) - hospitalize , intravenous antibiotic , stable FEV1 40-100 % predict enrol four week long pilot study where-in patient consume 40 gram flaxseed day , form finely ground flaxseed , however wish . Prior start flaxseed , week , four week patient finish take flaxseed , marker inflammation oxidative stress , well measurement flaxseed metabolism collect . F2-isoprostanes , 8-oxo-dGuo , well cytokine include IL-6 , TNF-a , IFN-g among others measure trend flaxseed effect . Enterolignans - enterodiol enterolactone ( product flaxseed metabolism ) measure week well .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<criteria>1 . Genetic clinical diagnosis cystic fibrosis ( CF ) 2 . FEV1 predict 40100 % 3 . Age 1864 4 . Pancreatic enzyme adherence ( pancreatic sufficiency ) 5 . Demonstration continue longterm dedication followup CF primary care provider 1 . Prior plan hospitalization surgical procedure within one month enrollment ( simple dental procedure ) 2 . An acute pulmonary exacerbation 3 . History bowel resection , inflammatory bowel disease distal intestinal obstruction syndrome 4 . Receiving broad spectrum intravenous antibiotic ( maintenance azithromycin , inhaled tobramycin , inhale aztreonam within one month enrollment ) 5 . Current supplementation FS soy derivative allergies 6 . Active prior ingestion Vitamin E exceed 30 IU within 21 day 7 . Significant liver disease ( cirrhosis ) 8 . Significant renal dysfunction ( GFR 50 ml/hr/m2 ) 9 . Poorly control diabetes ( evidence HgbA1c &gt; 7.5 % consistently blood glucose &gt; 250 mg/dl )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>cystic fibrosis</keyword>
	<keyword>isoprostanes</keyword>
	<keyword>8-oxo-dGuo</keyword>
	<keyword>oxidative stress</keyword>
	<keyword>inflammation</keyword>
	<keyword>flaxseed</keyword>
	<keyword>enterodiol</keyword>
	<keyword>enterolactone</keyword>
</DOC>